Latest return on equity
SAB Biotherapeutics Return on equity
SAB Biotherapeutics (SABS) return on equity with its verified observation date.
Direct answer
SAB Biotherapeutics's return on equity is -11.27%.
The verified market snapshot reports -11.27%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 29, 2026.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -11.27%
Explore related company data
View SAB Biotherapeutics's market capitalizationView SAB Biotherapeutics's p/e ratioView SAB Biotherapeutics's price-to-book ratioView SAB Biotherapeutics's 52-week price rangeView SAB Biotherapeutics's profit marginView SAB Biotherapeutics's debt-to-equity ratioView all SAB Biotherapeutics key metricsReturn to SAB Biotherapeutics profile